Loading insider details...
Beta
Latest Form 4 (Jun 11, 2026): Grant/Award of 6,000 TVRD shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 11, 2026 | Tvardi Therapeutics, Inc. (TVRD) | Grant/Award | 6,000 | n/a |
| Feb 27, 2026 | Mereo BioPharma Group plc (MREO) | Grant/Award | 66,000 | n/a |
| Jan 5, 2026 | X4 Pharmaceuticals, Inc (XFOR) | Grant/Award | 110,000 | n/a |
| Jun 10, 2025 | X4 Pharmaceuticals, Inc (XFOR) | Grant/Award | 1,500 | n/a |
| Apr 21, 2025 | Tvardi Therapeutics, Inc. (TVRD) | Grant/Award | 12,000 | n/a |
| Apr 17, 2025 | Tvardi Therapeutics, Inc. (TVRD) | Grant/Award | 18,441 | n/a |
| Feb 6, 2025 | Mereo BioPharma Group plc (MREO) | Grant/Award | 55,000 | n/a |
| Jun 17, 2024 | Mereo BioPharma Group plc (MREO) | Grant/Award | 25,050 | $99.9K |
| Jun 11, 2024 | X4 Pharmaceuticals, Inc (XFOR) | Grant/Award | 45,000 | n/a |
| Feb 9, 2024 | Mereo BioPharma Group plc (MREO) | Grant/Award | 45,000 | n/a |